# Alhemo

NDC: 0169-2084
Generic name: concizumab
Labeler / Manufacturer: Novo Nordisk
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20250219

FDA application: BLA761315

## Active ingredients

- CONCIZUMAB: 40 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0169-2084"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0169-2084
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=156f6404-1f6f-417f-bcf8-f07a27a82cc1